Results 31 to 40 of about 351,631 (301)

Serum microRNA-122 predicts survival in patients with liver cirrhosis

, 2012
Background: Liver cirrhosis is associated with high morbidity and mortality. MicroRNAs (miRs) circulating in the blood are an emerging new class of biomarkers.
Stefan Zeuzem, Albrecht Piiper (22854), Oliver Waidmann, Kronenberger, Bernd, Friederike Brunner, Verena Köberle (130993), Bernd Kronenberger (131004), Bernd Kronenberger, Verena Köberle, Waidmann, Oliver, Albrecht Piiper, Oliver Waidmann (130988), Piiper, Albrecht, Friederike Brunner (130998), Köberle, Verena, Brunner, Friederike, Zeuzem, Stefan, Stefan Zeuzem (22856)   +17 more
core   +1 more source

Renal Dysfunction in End-Stage Liver Disease and Post–Liver Transplant

, 2014
Renal dysfunction is a frequent complication in patients with end-stage liver disease awaiting orthotopic liver transplantation and in the post–liver transplant period.
Martin, Paul, Sampaio, Marcelo S, Bunnapradist, Suphamai   +2 more
core   +1 more source

Clinical presentation of autoimmune hepatitis in Pakistani children

The Pan African Medical Journal, 2018
INTRODUCTION: Autoimmune hepatitis (AIH) is one of the most common disorder resulting in end stage liver disease (ESLD) among children. Scarce data is available in this regard from Pakistan.
Ghous Bux Somroo, Ayesha Aslam Rai, Nasir Hassan Luck, Zaigham Abbas   +3 more
doaj   +1 more source

Sarcopenia in Children With End‐Stage Liver Disease

Journal of Pediatric Gastroenterology and Nutrition, 2018
ABSTRACTBackground:Sarcopenia, reflected by decreased psoas muscle surface area (PMSA), has been identified as a novel and independent predictor of wait‐list mortality and outcomes in adult liver transplantation (LT). We hypothesized that children with end‐stage liver disease (ESLD) would have smaller PMSA than healthy controls.Methods:Computer ...
Eberhard, Lurz, Hiten, Patel, Richard G, Frimpong, Amanda, Ricciuto, Mohit, Kehar, Paul W, Wales, Alexander J, Towbin, Govind B, Chavhan, Binita M, Kamath, Vicky L, Ng   +9 more
openaire   +3 more sources

Body composition and components of energy expenditure in children with end-stage liver disease

, 2003
Background: Better understanding of body composition and energy metabolism in pediatric liver disease may provide a scientific basis for improved medical therapy aimed at achieving optimal nutrition, slowing progression to end-stage liver disease (ESLD),
Cleghorn, Geoffrey J., Greer, Ristan, Shepherd, Ross W., Shepherd, R. W., Lewindon, Peter, Lewindon, P., Greer, R., Lehnert, Megan, Lehnert, M.   +8 more
core   +1 more source

Albumin for End-Stage Liver Disease

The Korean Journal of Internal Medicine, 2012
Albumin has been widely used in patients with cirrhosis in an attempt to improve circulatory and renal functions. The benefits of albumin infusions in preventing the deterioration in renal function associated with large-volume paracentesis, spontaneous bacterial peritonitis, and established hepatorenal syndrome in conjunction with a vasoconstrictor are
openaire   +2 more sources

Sarcopenia in end-stage liver disease and after liver transplantation

Acta Gastro Enterologica Belgica, 2023
Sarcopenia occurs in 30-70% of patients with end-stage liver disease and is associated with inferior pre- and post-liver transplant outcomes such as prolonged intubation times, long intensive care and hospitalization times, heightened risk of post-transplant infection, reduced health-related quality of life, and increased rates of mortality.
Leunis, S., Vandecruys, M., Craenenbroeck, A.H. Van, Cornelissen, V., Bogaerts, S., De Smet, S., Monbaliu, D.   +6 more
openaire   +2 more sources

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen, Calogero Virgone, Antje Redlich, Michael Abele, Ricardo Lopez‐Almaraz, Tal Ben‐Ami, Ewa Bien, Gianni Bisogno, Maja Mazic Cesen, Andrea Ferrari, Malgorzata A. Krawczyk, Yves Reguerre, Dominik T. Schneider, Ines B. Brecht, Charlotte Rigaud, Bilgehan Yalcin, Rainer Claus, Christian Vokuhl, Constantin Lapa, Jörg Fuchs, Segolene Hescot, Thomas Walter, Julien Hadoux, Daniel Orbach   +23 more
wiley   +1 more source

Role of Rifaximin in Prevention of Recurrent Hepatic Encephalopathy in Chronic Liver Disease

Journal of Bahria University Medical and Dental College, 2020
Objectives: To determine the efficacy (in terms of recurrence) of rifaximin in Hepatic Encephalopathy (HE) in chronic liver disease. Study Design and Setting: A descriptive study carried out from 4th September 2018 to 3rd March 2019 at the department of
Sahar Farzand, Abdul Latif Khattak, Rafi ud Din, Karamat Hussain Shah Bukhari, Muhammad Shahbaz Amin, Shahzeb Ahmed Satti   +5 more
doaj   +1 more source

Model for End-Stage Liver Disease: End of the First Decade [PDF]

Clinics in Liver Disease, 2011
The Model for End-stage Liver Disease (MELD) score is the basis for allocation of liver allografts for transplantation in the United States. The MELD score, as an objective scale of disease severity, is also used in the management of patients with chronic liver disease in the nontransplant setting.
Sumeet K, Asrani, W Ray, Kim
openaire   +2 more sources